Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

6 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
July 6, 2022 TSHA S 10b5-1 8,956 $3.79 $33,943 530,589 Direct -1.66% Disposed 22.2% (price as of 2026-10-02)
July 5, 2022 TSHA S 10b5-1 3,905 $3.51 $13,707 539,545 Direct -0.72% Disposed 31.9% (price as of 2026-10-02)
July 1, 2022 TSHA S 10b5-1 23,923 $3.53 $84,448 543,450 Direct -4.22% Disposed 31.2% (price as of 2026-10-02)
June 30, 2022 TSHA S 10b5-1 13,892 $3.72 $51,678 567,373 Direct -2.39% Disposed 24.5% (price as of 2026-10-02)
June 29, 2022 TSHA S 10b5-1 12,324 $3.81 $46,954 581,265 Direct -2.08% Disposed 21.5% (price as of 2026-10-02)
July 1, 2021 TSHA S 10b5-1 19,706 $21.12 $416,191 593,589 Direct -3.21% Disposed -78.1% (price as of 2026-10-02)
June 30, 2021 TSHA S 10b5-1 13,374 $21.42 $286,471 619,997 Direct -2.11% Disposed -78.4% (price as of 2026-10-02)
June 30, 2021 TSHA S 10b5-1 6,202 $22.44 $139,173 613,795 Direct -1.00% Disposed -79.4% (price as of 2026-10-02)
June 30, 2021 TSHA S 10b5-1 500 $23.70 $11,850 613,295 Direct -0.08% Disposed -80.5% (price as of 2026-10-02)
June 29, 2021 TSHA S 10b5-1 35,056 $23.74 $832,229 637,533 Direct -5.21% Disposed -80.5% (price as of 2026-10-02)
June 29, 2021 TSHA S 10b5-1 3,862 $24.46 $94,465 633,671 Direct -0.61% Disposed -81.1% (price as of 2026-10-02)
June 29, 2021 TSHA S 10b5-1 300 $25.19 $7,557 633,371 Direct -0.05% Disposed -81.6% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
April 6, 2022 TSHA Employee Stock Option (right to buy) Common Stock (40,325) $6.52 April 6, 2032 40,325 Acquired
Feb. 23, 2022 TSHA Employee Stock Option (right to buy) Common Stock (80,650) $5.96 Feb. 23, 2032 80,650 Acquired
Jan. 19, 2021 TSHA Stock Option (Right to Buy) Common Stock (80,000) $31.00 Jan. 19, 2031 80,000 Acquired
Sept. 28, 2020 TSHA Series B Preferred Stock Common Stock (3,844) · · 3,529 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Sept. 23, 2020 TSHA Series B Preferred Stock→ Common Stock (3,844) 3,844 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

TSHA

M.B.B.S, F.F.P.M. Chief Medical Officer and Head of Research and Development
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2021 $432,600 · · · $181,692 · $3,051 $2,231,064
2020 $216,833 · · · $129,975 · $152 $4,015,369

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.